These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 36071294)

  • 21. Clinical features and outcomes of patients with hemophagocytic lymphohistiocytosis at onset of systemic autoinflammatory disorder and compare with Epstein-Barr virus (EBV)-related hemophagocytic lymphohistiocytosis.
    Zhao Y; Li Z; Zhang L; Lian H; Ma H; Wang D; Zhao X; Zhang Q; Wang T; Zhang R
    Medicine (Baltimore); 2020 Jan; 99(1):e18503. PubMed ID: 31895784
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in adults and adolescents-a life-threatening disease: analysis of 133 cases from a single center.
    Lai W; Wang Y; Wang J; Wu L; Jin Z; Wang Z
    Hematology; 2018 Dec; 23(10):810-816. PubMed ID: 29957156
    [TBL] [Abstract][Full Text] [Related]  

  • 23. T Cell-Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis (HLH) Occurs in Non-Asians and Is Associated with a T Cell Activation State that Is Comparable to Primary HLH.
    Shamriz O; Kumar D; Shim J; Briones M; Quarmyne MO; Chonat S; Lucas L; Edington H; White MH; Mahajan A; Park S; Chandrakasan S
    J Clin Immunol; 2021 Oct; 41(7):1582-1596. PubMed ID: 34173902
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative study of biomarkers for the early identification of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in infectious mononucleosis.
    Cai L; Xing Y; Xia Y; Zhang Z; Luo Z; Tang Y; Chen Y; Xu X
    BMC Infect Dis; 2023 Oct; 23(1):728. PubMed ID: 37880605
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of Plasma Epstein-Barr Virus Nucleic Acid Loads on the Clinical Features and Prognosis in Adult Secondary Hemophagocytic Lymphohistiocytosis].
    Duan LM; Yin GL; Tian T; Wang JJ; Gao X; Cheng WY; Fang ZW; Qiu HX; Xu J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Aug; 32(4):1238-1247. PubMed ID: 39192426
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical features and outcome analysis of 83 childhood Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis with HLH-2004 protocol].
    Xiao L; Xian Y; Dai BT; Su YC; Xiao JW; Zheng QC; Zhao XD; Yu J
    Zhonghua Xue Ye Xue Za Zhi; 2011 Oct; 32(10):668-72. PubMed ID: 22339824
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of a screening score for Hemophagocytic Lymphohistiocytosis among pediatric patients with acute infection of Epstein-Barr virus.
    Li X; Yan H; Xiao Z; Luo T; Xie L; Yang Y; Gong L; Tang Z; Huang J; Zhang X; Zheng M; Yao Z; Zang P; Zhu D; Lu X
    Front Immunol; 2022; 13():981251. PubMed ID: 36172365
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spontaneous Recovery of Hemophagocytic Lymphohistiocytosis Due to Primary Epstein-Barr Virus Infection in an Adult Patient.
    Matsuo Y; Iwanami K; Hiraoka E; Oda R
    Am J Case Rep; 2021 Oct; 22():e933272. PubMed ID: 34657119
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical warning of hemophagocytic syndrome caused by Epstein-Barr virus.
    Shi J; Chu C; Yu M; Zhang D; Li Y; Fan Y; Yu Y; Luo Y; Zhou W
    Ital J Pediatr; 2021 Jan; 47(1):3. PubMed ID: 33413556
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rescue of HLH with T and B Lymphocyte Involvement Due to Epstein-Barr Virus by PD-1 Inhibitor/Ruxolitinib and Rituximab Combination Regimens: A Case Report.
    Zhu M; Zhang J; Shi Q; Sun X; Wang H; Sun M; Liu Y
    Iran J Immunol; 2023 Dec; 20(4):466-472. PubMed ID: 37873944
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis during pregnancy].
    Ikeda M; Oba R; Yoshiki Y; Shingaki S; Takei T; Miyazaki K; Abe Y; Tsukada N; Ishida T; Suzuki K
    Rinsho Ketsueki; 2017; 58(3):216-221. PubMed ID: 28381688
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Therapeutic Effect of PE+CRRT Combined with Chemotherapy on Children with Severe EBV-HLH and Non-EBV-HLH].
    Long YY; Huang CS; Huang P; Xu HB; Xie C; Chen Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Feb; 29(1):259-264. PubMed ID: 33554831
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment outcomes and prognostic analysis of 61 Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis].
    Zeng X; Wei N; Wang Y; Wang J; Zhang J; Wu L; Huang W; Gao Z; Pei R; Chen J; Jin Z; Wang Z
    Zhonghua Xue Ye Xue Za Zhi; 2015 Jun; 36(6):507-10. PubMed ID: 26134018
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emapalumab as a therapeutic intervention for Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis: A case series.
    Wang W; Yuan X; Yu L; Pei F
    Medicine (Baltimore); 2024 Sep; 103(39):e39880. PubMed ID: 39331881
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hematopoietic stem cell transplantation for familial hemophagocytic lymphohistiocytosis and Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in Japan.
    Ohga S; Kudo K; Ishii E; Honjo S; Morimoto A; Osugi Y; Sawada A; Inoue M; Tabuchi K; Suzuki N; Ishida Y; Imashuku S; Kato S; Hara T
    Pediatr Blood Cancer; 2010 Feb; 54(2):299-306. PubMed ID: 19827139
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of Epstein Barr virus-induced haemophagocytic lymphohistiocytosis with rituximab-containing chemo-immunotherapeutic regimens.
    Chellapandian D; Das R; Zelley K; Wiener SJ; Zhao H; Teachey DT; Nichols KE;
    Br J Haematol; 2013 Aug; 162(3):376-82. PubMed ID: 23692048
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Malignancy-associated hemophagocytic lymphohistiocytosis in children: a 10-year experience of a single pediatric hematology center.
    Huang Z; Jia Y; Zuo Y; Wu J; Lu A; Zhang L
    Hematology; 2020 Dec; 25(1):389-399. PubMed ID: 33161882
    [No Abstract]   [Full Text] [Related]  

  • 38. Single-Cell Transcriptomic Analysis of Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis.
    Suzuki T; Sato Y; Okuno Y; Torii Y; Fukuda Y; Haruta K; Yamaguchi M; Kawamura Y; Hama A; Narita A; Muramatsu H; Yoshikawa T; Takahashi Y; Kimura H; Ito Y; Kawada JI
    J Clin Immunol; 2024 Apr; 44(4):103. PubMed ID: 38642164
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Haemophagocytic lymphohistiocytosis and Epstein-Barr virus: a complex relationship with diverse origins, expression and outcomes.
    El-Mallawany NK; Curry CV; Allen CE
    Br J Haematol; 2022 Jan; 196(1):31-44. PubMed ID: 34169507
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Characteristic and prognosis of patients with non-EBV infection-associated hemophagocytic lymphohistiocytosis].
    You YH; Wang JS; Wang Z
    Zhonghua Xue Ye Xue Za Zhi; 2022 Feb; 43(2):128-133. PubMed ID: 35381673
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.